Back to results
US 2006/0069135 A1Published application
Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
OwnerLene Teuber, Janus Larseninventors
Life of this patent
Estimating the term…
Abstract
This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex, and in particular for combating anxiety and related diseases.
Claims11
A compound of general formula (I):
- or an N-oxide thereof, or any of its isomers or any mixture of its isomers,
- or a pharmaceutically acceptable salt thereof,
- wherein
- R represents hydroxyalkyl, alkoxyalkyl, cycloalkoxyalkyl, cycloalkylalkoxyalkyl, alkenyloxyalkyl, or alkynyloxyalkyl;
- and
- R′ represents a 5-membered heterocyclic ring;
- which heterocyclic ring may optionally be substituted with one or more substituents independently selected from the group consisting of halo, hydroxy, amino, alkylamino, aminoalkyl, cyano, nitro, trifluoromethyl, trifluoromethoxy, alkoxy, cycloalkoxy, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, and alkynyl.
4 more elements
(canceled)
Dependencies are inferred from the claim text.